Literature DB >> 16333031

Chronic stress and susceptibility to skin cancer.

Alison N Saul1, Tatiana M Oberyszyn, Christine Daugherty, Donna Kusewitt, Susie Jones, Scott Jewell, William B Malarkey, Amy Lehman, Stanley Lemeshow, Firdaus S Dhabhar.   

Abstract

BACKGROUND: Studies have shown that chronic stress or UV radiation independently suppress immunity. Given their increasing prevalence, it is important to understand whether and how chronic stress and UV radiation may act together to increase susceptibility to disease. Therefore, we investigated potential mediators of a stress-induced increase in emergence and progression of UV-induced squamous cell carcinoma.
METHODS: SKH1 mice susceptible to UV-induced tumors were unexposed (naïve, n = 4) or exposed (n = 16) to 2240 J/m2 of UVB radiation three times a week for 10 weeks. Half of the UVB-exposed mice were left nonstressed (i.e., they remained in their home cages) and the other half were chronically stressed (i.e., restrained during weeks 4-6). UV-induced tumors were measured weekly from week 11 through week 34, blood was collected at week 34, and tissues were collected at week 35. mRNA expression of interleukin (IL)-12p40, interferon (IFN)-gamma, IL-4, IL-10, CD3epsilon, and CCL27/CTACK, the skin T cell-homing chemokine, in dorsal skin was quantified using real-time polymerase chain reaction. CD4+, CD8+, and CD25+ leukocytes were counted using immunohistochemistry and flow cytometry. All statistical tests were two-sided.
RESULTS: Stressed mice had a shorter median time to first tumor (15 versus 16.5 weeks, difference = 1.5 weeks, 95% confidence interval [CI] = -3.0 to 3.3 weeks; P = .03) and reached 50% incidence earlier than controls (15 weeks versus 21 weeks). Stressed mice also had lower IFN-gamma ( mean = 0.03 versus mean = 0.07, difference = 0.04, 95% CI = 0.004 to 0.073; P = .02), CCL27/CTACK (mean = 101 versus mean = 142, difference = 41, 95% CI = 8.1 to 74.4; P = .03), and CD3epsilon (mean = 0.18 versus mean = 0.36, difference = 0.18, 95% CI = 0.06 to 0.30; P = .007) gene expression and lower numbers of infiltrating CD4+ cells (mean = 9.40 versus mean = 13.7, difference = 4.3, 95% CI = 2.36 to 6.32; P = .008) than nonstressed mice. In addition, stressed mice had more regulatory/suppressor CD25+ cells infiltrating tumors and more CD4+ CD25+ cells in circulation (mean = 0.36 versus mean = 0.17, difference = 0.19, 95% CI = 0.005 to 0.38; P = .03) than nonstressed mice.
CONCLUSIONS: Chronic stress increased susceptibility to UV-induced squamous cell carcinoma in this mouse model by suppressing type 1 cytokines and protective T cells and increasing regulatory/suppressor T cell numbers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16333031      PMCID: PMC3422720          DOI: 10.1093/jnci/dji401

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  49 in total

1.  Neuroendocrine and immunological mechanisms in stress-induced immunomodulation.

Authors:  F Berkenbosch; D A Wolvers; R Derijk
Journal:  J Steroid Biochem Mol Biol       Date:  1991       Impact factor: 4.292

Review 2.  Restraint stress in biomedical research: an update.

Authors:  G B Glavin; W P Paré; T Sandbak; H K Bakke; R Murison
Journal:  Neurosci Biobehav Rev       Date:  1994       Impact factor: 8.989

3.  Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats.

Authors:  P M Plotsky; M J Meaney
Journal:  Brain Res Mol Brain Res       Date:  1993-05

4.  Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats.

Authors:  R Kvetnanský; K Fukuhara; K Pacák; G Cizza; D S Goldstein; I J Kopin
Journal:  Endocrinology       Date:  1993-09       Impact factor: 4.736

5.  Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

Authors:  A S Dighe; E Richards; L J Old; R D Schreiber
Journal:  Immunity       Date:  1994-09       Impact factor: 31.745

6.  Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats.

Authors:  F S Dhabhar; A H Miller; B S McEwen; R L Spencer
Journal:  J Neuroimmunol       Date:  1995-01       Impact factor: 3.478

7.  Detection of p53 and histopathological classification of skin tumours induced by halogen lamps in hairless mice.

Authors:  F D'Agostini; P Fiallo; C Di Marco; S De Flora
Journal:  Cancer Lett       Date:  1994-11-11       Impact factor: 8.679

8.  Ultraviolet radiation and immunology: something new under the sun--presidential address.

Authors:  M L Kripke
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

9.  Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations.

Authors:  F S Dhabhar; A H Miller; M Stein; B S McEwen; R L Spencer
Journal:  Brain Behav Immun       Date:  1994-03       Impact factor: 7.217

10.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.

Authors:  R Manetti; P Parronchi; M G Giudizi; M P Piccinni; E Maggi; G Trinchieri; S Romagnani
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  65 in total

1.  Basal cell carcinoma: stressful life events and the tumor environment.

Authors:  Christopher P Fagundes; Ronald Glaser; Sheri L Johnson; Rebecca R Andridge; Eric V Yang; Michael P Di Gregorio; Min Chen; David R Lambert; Scott D Jewell; Mark A Bechtel; Dean W Hearne; Joel B Herron; Janice K Kiecolt-Glaser
Journal:  Arch Gen Psychiatry       Date:  2012-06

2.  Stress and skin leukocyte trafficking as a dual-stage process.

Authors:  Elad Neeman; Lee Shaashua; Marganit Benish; Gayle G Page; Oded Zmora; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-09-19       Impact factor: 7.217

Review 3.  Neuroendocrine influences on cancer progression.

Authors:  Guillermo N Armaiz-Pena; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Journal:  Brain Behav Immun       Date:  2012-06-21       Impact factor: 7.217

Review 4.  Host factors and cancer progression: biobehavioral signaling pathways and interventions.

Authors:  Susan K Lutgendorf; Anil K Sood; Michael H Antoni
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

5.  Stress-induced redistribution of immune cells--from barracks to boulevards to battlefields: a tale of three hormones--Curt Richter Award winner.

Authors:  Firdaus S Dhabhar; William B Malarkey; Eric Neri; Bruce S McEwen
Journal:  Psychoneuroendocrinology       Date:  2012-06-22       Impact factor: 4.905

6.  hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.

Authors:  M J Choi; K H Cho; S Lee; Y J Bae; K J Jeong; S Y Rha; E J Choi; J H Park; J M Kim; J-S Lee; G B Mills; H Y Lee
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

7.  Chronic unpredictable stress (CUS) enhances the carcinogenic potential of 7,12-dimethylbenz(a)anthracene (DMBA) and accelerates the onset of tumor development in Swiss albino mice.

Authors:  Nida Suhail; Nayeem Bilal; Shirin Hasan; Ausaf Ahmad; Ghulam Md Ashraf; Naheed Banu
Journal:  Cell Stress Chaperones       Date:  2015-08-14       Impact factor: 3.667

8.  VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine.

Authors:  Eric V Yang; Elise L Donovan; Don M Benson; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2007-11-05       Impact factor: 7.217

9.  Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice.

Authors:  Amy M Dworkin; Kathleen L Tober; F Jason Duncan; Lianbo Yu; Anne M VanBuskirk; Tatiana M Oberyszyn; Amanda Ewart Toland
Journal:  Genes Chromosomes Cancer       Date:  2009-06       Impact factor: 5.006

10.  Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression.

Authors:  Eric V Yang; Seung-jae Kim; Elise L Donovan; Min Chen; Amy C Gross; Jeanette I Webster Marketon; Sanford H Barsky; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2008-10-21       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.